Haggis@wk wrote:If the big drug companies thought there was any money to be made from stem cell research then they'd make the money available to research it, full stop.
...My point was simply that they don't seem to regard stem cell as the pharmaceutical Holy Grail that the popular press is claiming. ...Or maybe they’ve looked at the available information and their college graduates decided there’s no “there” there.
Just my opinion.
Semi-cynical speculation follows:
Stem cell research is aimed at correcting health problems, by replacing the defective tissues with new tissue that will do the biological job. Drug companies are in the business of selling stuff that will treat health problems rooted (in many cases) in the tissues the stem-cell-derived new tissue will (hopefully) replace.
If some tissue genius in a lab figures out how to tweek some stem cells into being the tissue that generates the biochemical fix for Type II diabetes, sales of Glucophage and Avandia and Glynase et al will go through not the roof, but the floor. It is not in the drug company's best interests to fund this research; they'd rather research ways to trick bacteria into making human insulin - cheap, clean, and profitable.
In other words, there might be a "there" there, but is it a "there" the company wants to explore?